Literature DB >> 23000944

The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.

Hassnae Afrache1, Philippe Gouret, Shanaiz Ainouche, Pierre Pontarotti, Daniel Olive.   

Abstract

Butyrophilins (BTN) belong to the immunoglobulin (Ig) superfamily of transmembrane proteins. These molecules are of increasing interest to immunologists, as they share a structural homology with B7 family members at the extracellular domain level. Moreover, a role of these molecules has been suggested in the negative regulation of lymphocyte activation for almost all the BTN that have been studied. In addition, the expression of some BTN family members has been reported to be associated with autoimmune diseases. Over the last few years, the number of BTN and BTN-like members has greatly increased. In this study, the butyrophilin family in mammals has been revisited, using phylogenetic analysis to identify all the family members and the phylogenetic relations among them, and to establish a standard nomenclature. Fourteen BTN groups were identified that are not all conserved between mammalian species. In addition, an overview of expression profiles and functional BTN data demonstrates that these molecules represent a new area of investigation for the design of future strategies in the modulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000944     DOI: 10.1007/s00251-012-0619-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

1.  Differential loss of embryonic globin genes during the radiation of placental mammals.

Authors:  Juan C Opazo; Federico G Hoffmann; Jay F Storz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

2.  Cloning, localization, and structure of new members of the butyrophilin gene family in the juxta-telomeric region of the major histocompatibility complex.

Authors:  R Tazi-Ahnini; J Henry; C Offer; C Bouissou-Bouchouata; I H Mather; P Pontarotti
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

3.  Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.

Authors:  Nassima Messal; Emilie Mamessier; Aude Sylvain; Javier Celis-Gutierrez; Marie-Laure Thibult; Bruno Chetaille; Guylène Firaguay; Sonia Pastor; Yves Guillaume; Qian Wang; Ivan Hirsch; Jacques A Nunès; Daniel Olive
Journal:  Eur J Immunol       Date:  2011-11-03       Impact factor: 5.532

4.  Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity.

Authors:  Hiromichi Yamashiro; Shinji Yoshizaki; Toshimasa Tadaki; Kohji Egawa; Naohiro Seo
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

5.  Human ERMAP: an erythroid adhesion/receptor transmembrane protein.

Authors:  Y Y Su; C T Gordon; T Z Ye; A C Perkins; D H Chui
Journal:  Blood Cells Mol Dis       Date:  2001 Sep-Oct       Impact factor: 3.039

6.  Structure and dimerization of a soluble form of B7-1.

Authors:  S Ikemizu; R J Gilbert; J A Fennelly; A V Collins; K Harlos; E Y Jones; D I Stuart; S J Davis
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

7.  A butyrophilin family member critically inhibits T cell activation.

Authors:  Tomohide Yamazaki; Iñigo Goya; Daniel Graf; Suzanne Craig; Natalia Martin-Orozco; Chen Dong
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

8.  CASSIOPE: an expert system for conserved regions searches.

Authors:  Virginie Lopez Rascol; Anthony Levasseur; Olivier Chabrol; Simona Grusea; Philippe Gouret; Etienne G J Danchin; Pierre Pontarotti
Journal:  BMC Bioinformatics       Date:  2009-09-10       Impact factor: 3.169

Review 9.  Regulation of costimulation in the era of butyrophilins.

Authors:  Heather A Arnett; Sabine S Escobar; Joanne L Viney
Journal:  Cytokine       Date:  2009-04-19       Impact factor: 3.861

10.  BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation.

Authors:  Isobel A Smith; Brittany R Knezevic; Johannes U Ammann; David A Rhodes; Danielle Aw; Donald B Palmer; Ian H Mather; John Trowsdale
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

View more
  43 in total

1.  A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells.

Authors:  Charlotte Esser
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

2.  BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.

Authors:  Xiaohong Tian; Yujun Lin; Cheng Cui; Min Su; Laijun Lai
Journal:  Adv Healthc Mater       Date:  2019-03-18       Impact factor: 9.933

Review 3.  Immune modulation by butyrophilins.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

Review 4.  The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.

Authors:  Kathleen M Mahoney; Gordon J Freeman; David F McDermott
Journal:  Clin Ther       Date:  2015-03-29       Impact factor: 3.393

Review 5.  γδ T cells in tissue physiology and surveillance.

Authors:  Julie C Ribot; Noëlla Lopes; Bruno Silva-Santos
Journal:  Nat Rev Immunol       Date:  2020-10-14       Impact factor: 53.106

6.  Skint8, a Novel B7 Family-Related Molecule, Negatively Regulates T Cell Responses.

Authors:  Yujun Lin; Cheng Cui; Min Su; Xiaohong Tian; Yuanmao Huang; Jin Zhao; Laijun Lai
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

7.  Evolutionary and polymorphism analyses reveal the central role of BTN3A2 in the concerted evolution of the BTN3 gene family.

Authors:  Hassnae Afrache; Pierre Pontarotti; Laurent Abi-Rached; Daniel Olive
Journal:  Immunogenetics       Date:  2017-04-05       Impact factor: 2.846

Review 8.  Harnessing the power of Vδ2 cells in cancer immunotherapy.

Authors:  D W Fowler; M D Bodman-Smith
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

9.  Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model.

Authors:  Nicholas A Zumwalde; Akshat Sharma; Xuequn Xu; Shidong Ma; Christine L Schneider; James C Romero-Masters; Amy W Hudson; Annette Gendron-Fitzpatrick; Shannon C Kenney; Jenny E Gumperz
Journal:  JCI Insight       Date:  2017-07-06

10.  In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice.

Authors:  Cheng Cui; Xiaohong Tian; Yujun Lin; Min Su; Qingquan Chen; Shao-Yuan Wang; Laijun Lai
Journal:  Cell Immunol       Date:  2018-10-26       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.